/Companies

Baxiva

1 known investors

Find your way into Baxiva

Sign up to see every warm intro you have to Baxiva

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Baxiva team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.

Investors · 1

Frequently asked questions

What does Baxiva do?
Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
Who are Baxiva's investors?
Baxiva's investors include Kickfund.